CClinicalTrials.gg
CompletedNCT00403572Updated Oct 17, 2016

A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia

An observational study in Preeclampsia, sponsored by Oslo University Hospital. Completed. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2016-10-17.

Sponsored by Oslo University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
8
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The purpose of this study is a systematical registration of hemodynamic measurements (cardiac output, blood pressure and systemic vascular resistance) in women with serious preeclampsia.

02

Conditions studied

  • Preeclampsia

Browse trials for

Keywords

  • Preeclampsia
  • Trans cranial Doppler
  • Cardiac output
  • systemic vascular resistance
  • blood pressure
03

In context

Pre-Eclampsia

882 studies on the registry are indexed under Pre-Eclampsia; 237 are open to participants now.

This study's enrollment of 8 is below the median of 163 across 380 observational studies indexed under Pre-Eclampsia.

Browse Pre-Eclampsia studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women with moderate-to-severe pre-eclapmsia

Eligibility criteria

Inclusion Criteria:

  • Women with serious preeclampsia
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
8 participants (actual)
06

What researchers measure

Primary outcomes

  1. Hemodynamic and cerebral-circulatory variations in preeclamptic women

    Time frame: days

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 17, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00403572
Lead sponsor
Oslo University Hospital
Responsible party
Eldrid Langesæter (MD PhD, Oslo University Hospital) — Principal investigator
First posted
Nov 23, 2006
Start date
Nov 2006
Primary completion
Jan 2009
Completion
Jan 2009
Last update
Oct 17, 2016

Study contacts

Eldrid Langesæter, PhD, MD
principal investigator · Oslo University Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion